3t6p
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerization== | ==IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerization== | ||
| - | <StructureSection load='3t6p' size='340' side='right' caption='[[3t6p]], [[Resolution|resolution]] 1.90Å' scene=''> | + | <StructureSection load='3t6p' size='340' side='right'caption='[[3t6p]], [[Resolution|resolution]] 1.90Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3t6p]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3t6p]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3T6P OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3T6P FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">API1, BIRC2, IAP2, MIHB, RNF48 ([ | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">API1, BIRC2, IAP2, MIHB, RNF48 ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3t6p FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3t6p OCA], [https://pdbe.org/3t6p PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3t6p RCSB], [https://www.ebi.ac.uk/pdbsum/3t6p PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3t6p ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [[ | + | [[https://www.uniprot.org/uniprot/BIRC2_HUMAN BIRC2_HUMAN]] Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling, and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, TRAF2, DIABLO/SMAC, MAP3K14/NIK, MAP3K5/ASK1, IKBKG/NEMO and MXD1/MAD1. Can also function as an E3 ubiquitin-protein ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. Can stimulate the transcriptional activity of E2F1. Plays a role in the modulation of the cell cycle.<ref>PMID:15665297</ref> <ref>PMID:18082613</ref> <ref>PMID:21145488</ref> <ref>PMID:21653699</ref> <ref>PMID:21931591</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 3t6p" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 3t6p" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Baculoviral IAP repeat-containing protein|Baculoviral IAP repeat-containing protein]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 27: | Line 24: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Deshayes, K]] | [[Category: Deshayes, K]] | ||
[[Category: Dueber, E C]] | [[Category: Dueber, E C]] | ||
Revision as of 16:45, 6 July 2022
IAP antagonist-induced conformational change in cIAP1 promotes E3 ligase activation via dimerization
| |||||||||||
Categories: Human | Large Structures | Deshayes, K | Dueber, E C | Elliott, M | Fairbrother, W J | Fedorova, A V | Giannetti, A M | Hymowitz, S | Lingel, A | Maurer, B | Schoeffler, A J | Varfolomeev, E | Vucic, D | Wallweber, H | Wu, P | Zobel, K | Apoptosis | Bir | Card | Caspase | E3 | Iap family | Ring | Smac mimetic | Smac/diablo | Uba | Ubiquitin | Ubiquitin ligase
